271 related articles for article (PubMed ID: 23174623)
1. Aliskiren inhibits experimental venous thrombosis in two-kidney one- clip hypertensive rats.
Hermanowicz JM; Hermanowicz A; Buczko P; Leszczynska A; Tankiewicz-Kwedlo A; Mogielnicki A; Buczko W
Thromb Res; 2013 Jan; 131(1):e39-44. PubMed ID: 23174623
[TBL] [Abstract][Full Text] [Related]
2. Impact of aliskiren on some hemostatic parameters in experimental arterial thrombosis in rats.
Hermanowicz JM; Buczko P; Tankiewicz-Kwedlo A; Hermanowicz A; Buczko W
Pharmacol Rep; 2015 Apr; 67(2):173-8. PubMed ID: 25712636
[TBL] [Abstract][Full Text] [Related]
3. N-methylnicotinamide inhibits arterial thrombosis in hypertensive rats.
Mogielnicki A; Kramkowski K; Pietrzak L; Buczko W
J Physiol Pharmacol; 2007 Sep; 58(3):515-27. PubMed ID: 17928647
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide and prostacyclin are involved in antithrombotic action of captopril in venous thrombosis in rats.
Pawlak R; Chabielska E; Golatowski J; Azzadin A; Buczko W
Thromb Haemost; 1998 Jun; 79(6):1208-12. PubMed ID: 9657449
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic activity of losartan in two kidney, one clip hypertensive rats. A study on the mechanism of action.
Chabielska E; Pawlak R; Wollny T; Rółkowski R; Buczko W
J Physiol Pharmacol; 1999 Mar; 50(1):99-109. PubMed ID: 10210158
[TBL] [Abstract][Full Text] [Related]
7. Aliskiren reduces portal pressure in portal hypertensive rats.
Chang CC; Lee WS; Huang HC; Lee FY; Wang SS; Lin HC; Nong JY; Lee SD
Eur J Clin Invest; 2012 May; 42(5):526-33. PubMed ID: 22023532
[TBL] [Abstract][Full Text] [Related]
8. Thiol repletion prevents venous thrombosis in rats by nitric oxide/prostacyclin-dependent mechanism: relation to the antithrombotic action of captopril.
Pawlak R; Chabielska E; Matys T; Kucharewicz I; Rółkowski R; Buczko W
J Cardiovasc Pharmacol; 2000 Oct; 36(4):503-9. PubMed ID: 11026653
[TBL] [Abstract][Full Text] [Related]
9. The involvement of AT(2)-receptor in the antithrombotic effect of losartan in renal hypertensive rats.
Chabielska E; Matys T; Kucharewicz I; Pawlak D; Rólkowski R; Buczko W
J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):263-7. PubMed ID: 11881035
[TBL] [Abstract][Full Text] [Related]
10. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
[TBL] [Abstract][Full Text] [Related]
11. Effects of aliskiren, a renin inhibitor, on biomarkers of platelet activity, coagulation and fibrinolysis in subjects with multiple risk factors for vascular disease.
Serebruany VL; Malinin A; Barsness G; Vahabi J; Atar D
J Hum Hypertens; 2008 May; 22(5):303-10. PubMed ID: 18273042
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II enhances thrombosis development in renovascular hypertensive rats.
Mogielnicki A; Chabielska E; Pawlak R; Szemraj J; Buczko W
Thromb Haemost; 2005 Jun; 93(6):1069-76. PubMed ID: 15968390
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effect of combined spironolactone and quinapril treatment on thrombosis and hemostasis in 2K1C hypertensive rats.
Gromotowicz-Poplawska A; Stankiewicz A; Mikita J; Aleksiejczuk M; Marcinczyk N; Szemraj J; Chabielska E
J Physiol Pharmacol; 2018 Apr; 69(2):. PubMed ID: 29980144
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7).
Kucharewicz I; Pawlak R; Matys T; Pawlak D; Buczko W
Hypertension; 2002 Nov; 40(5):774-9. PubMed ID: 12411476
[TBL] [Abstract][Full Text] [Related]
15. Aliskiren prevents hypertension and reduces asymmetric dimethylarginine in young spontaneously hypertensive rats.
Tain YL; Hsu CN; Lin CY; Huang LT; Lau YT
Eur J Pharmacol; 2011 Nov; 670(2-3):561-5. PubMed ID: 21946111
[TBL] [Abstract][Full Text] [Related]
16. Direct renin inhibition is not enough to prevent reactive oxygen species generation and vascular dysfunction in renovascular hypertension.
Martins-Oliveira A; Guimaraes DA; Ceron CS; Rizzi E; Oliveira DMM; Tirapelli CR; Casarini DE; Fernandes FB; Pinheiro LC; Tanus-Santos JE
Eur J Pharmacol; 2018 Feb; 821():97-104. PubMed ID: 29331564
[TBL] [Abstract][Full Text] [Related]
17. [The future of renin inhibition].
Uresin AY; Baran E
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotic effect of captopril and enalapril in young rats.
Buczko W; Kubik A; Kucharewicz I; Chabielska E
Pol J Pharmacol; 2004; 56(1):97-104. PubMed ID: 15047983
[TBL] [Abstract][Full Text] [Related]
19. The direct renin inhibitor aliskiren improves vascular remodelling in transgenic rats harbouring human renin and angiotensinogen genes.
Savoia C; Arrabito E; Parente R; Sada L; Madaro L; Nicoletti C; Zezza L; Alonzo A; Rubattu S; Michelini S; Muller DN; Volpe M
Clin Sci (Lond); 2013 Aug; 125(4):183-9. PubMed ID: 23438195
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic evaluation of rutin in two-kidney one-clip model of renovascular hypertension in rat.
Kaur S; Muthuraman A
Life Sci; 2016 Apr; 150():89-94. PubMed ID: 26920631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
